Vanguard: We’re not troubled by duration in Lifestrategy
Vanguard has faced criticism for soaring duration in its fixed allocation Lifestrategy range, but investment strategist Ankul Daga is doubtful tactical decisions made by active managers will deliver superior results.
Investors pile into Vanguard ETF despite launch of cheaper rival
European investors have piled into a Vanguard ETF tracking the S&P 500, despite the launch of a cheaper rival tracking US large-cap companies.
Investors exposed to soaring duration in Vanguard Lifestrategy
Vanguard’s £9.6bn Lifestrategy range is exposing investors to interest rate risk, as governments and corporates buying up cheap, long-dated debt skew duration in indices that the passives giant tracks.
Mifid II exposes ‘charging grubbiness’ of top 20 funds
Some of the biggest names in UK retail are charging investors nearly double the ongoing charges figure (OCF) of their funds, Mifid II regulations have brought to light.
US equity and iShares dominate European ETF market
US equity exchanged traded funds (ETFs) were the preferred product for European investors looking at the ETF market in 2017, accounting for 15% of the market’s assets under management (AUM), according to Thompson Reuters Lipper research.